Results 231 to 240 of about 334,765 (343)
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons+17 more
wiley +1 more source
Abstract Increasingly, it has been recognized that non‐seizure‐related factors influence how people with epilepsy perform on neuropsychological tests. Therefore, neuropsychologists need to recognize the constellation of factors that can contribute to the neurocognitive presentation of a person with epilepsy and consider these factors in the ...
Mary Lou Smith+12 more
wiley +1 more source
Neurobiological basis of autism spectrum disorder: mini review. [PDF]
Holanda MVF+10 more
europepmc +1 more source
Reduced melatonin synthesis is a risk factor for autism spectrum disorders [PDF]
openalex +1 more source
Abstract Although inborn errors of metabolism (IEM) are a rare cause of epilepsy, seizures are a common presentation in these disorders. Seizures in IEM are frequently refractory to conventional anti‐seizure medication and might warrant initiation of specific treatments based on vitamins or dietary modifications or provision of alternative substrates ...
D. Kapoor+7 more
wiley +1 more source
The Evolving Landscape of Functional Models of Autism Spectrum Disorder. [PDF]
Ranjan J, Bhattacharya A.
europepmc +1 more source
Abstract The accurate interpretation of scalp EEG remains an instrumental diagnostic component of epilepsy care. Knowledge of what constitutes normal EEG findings, non‐epileptiform abnormalities, and epileptiform patterns—both ictal and interictal—is essential for appropriate patient management.
Juan Luis Alcala‐Zermeno+9 more
wiley +1 more source
Catatonia and autism spectrum disorder: A common comorbid syndrome or a core feature? [PDF]
Mahgoub Y, Hamlin D, Kindt H, Francis A.
europepmc +1 more source